Latest Going Concern News

Avenira has pushed its first Wonarah phosphate shipment target into the first half of 2027, while its auditor warned that funding remains critical to the company’s survival. The annual report records project progress, but also a $3.34 million loss, $759,415 in year-end cash and a proposed $49 million rights issue.

Key Petroleum reduced its FY2026 loss, but the oil and gas explorer continues to rely on equity funding while awaiting Queensland Government decisions on ATP 920 and ATP 924. An auditor’s unmodified opinion still highlights material uncertainty over the company’s ability to continue as a going concern.

West Cobar Metals ended FY2026 with more cash but a larger loss and an auditor-highlighted material uncertainty over its ability to continue without further funding. Exploration advanced across Salazar and Cobar West, but the company remains dependent on equity markets to keep its programmes moving.

Santana Minerals has moved Bendigo-Ophir from study toward construction, securing a 30-year mining permit, strategic land control and A$188.3 million in cash. The decisive hurdle remains the Fast-track consent due on 20 January 2027, followed by financing and a final investment decision.

Melbana Energy’s Block 9 project remains on care and maintenance after a partner default and US sanctions on CUPET, despite improved geological understanding from Amistad-2. The company ended FY2026 with $472,504 in cash and warned that additional funding is required to continue.

Green360 Technologies has moved its MKX metakaolin product from testing into commercial supply, securing a binding agreement with Holcim Australia while cutting annualised fixed cash costs by about $1.6 million. The progress comes against a $4.25 million FY2026 loss, $3.93 million in operating cash outflows and an explicit need to prove the business can scale before its cash buffer runs down.

Mithril Silver and Gold has lifted the higher-confidence portion of its Copalquin Target 1 resource to 464,000 ounces of gold equivalent, giving the Mexican project a stronger base for mine planning. The upgrade comes alongside a larger loss, substantial exploration spending and an auditor’s warning that further funding is needed to support the company’s going-concern status.

Resources & Energy Group has reported a standout 9-metre gold intercept at Goodenough as it prepares a fresh resource estimate. The exploration progress arrives alongside an audited warning that further funding is needed to sustain the business.

Auravelle Metals has reported encouraging gold results at Sheoak and expanded its Crown project, but its FY2026 annual report flags a material uncertainty over its ability to continue as a going concern. The company lost A$3.98 million, used A$4.07 million in operating cash and held A$632,721 at year end before completing a further A$1.5 million placement.

IODM Limited (ASX:IOD) increased FY2026 revenue by 16.9% and narrowed its net loss, but auditors flagged material uncertainty over the company’s ability to continue as a going concern. A post-year-end A$1.00 million placement is funding an expansion into North American universities while the business remains heavily reliant on external capital.

Patrys has moved its injectable quetiapine program into human testing, while its FY2026 annual report warns the company will need further funding within 12 months. The company ended the year with $3.36 million in cash after raising capital and acquiring the RLS-2202 development program.

Cynata Therapeutics (ASX:CYP) has reported a $9.25 million loss, negative net assets and a material uncertainty over going concern after its two major clinical trials failed to demonstrate efficacy. The company has since cut its workforce to zero, shifted management to the board and secured a $600,000 R&D tax incentive loan while it considers the future of its Cymerus platform.